Kyverna Therapeutics, Inc. KYTX
5.22 USD +0.14 (+2.76%)
Nov 11, 2026, 12:34 PM EST
5.02 Day range 5.23
4.50 52-week range 13.67
- YTD
- -44.47%
- 1 year
- -25.43%
Held by funds
65 US ETFs and mutual funds hold KYTX · largest positions
Ownership
Held by insiders 10.78%
Held by institutions 76.11%
Float held by institutions 85.30%
Institutions 132
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vida Ventures Advisors, LLC | 10.48% | 4,523,924 | 17.73M | Sep 29, 2024 |
| Bain Capital Life Sciences Investors, LLC | 7.80% | 3,368,370 | 13.20M | Sep 29, 2024 |
| Northpond Ventures, Llc | 7.54% | 3,255,426 | 12.76M | Sep 29, 2024 |
| JP Morgan Chase & Company | 5.53% | 2,387,352 | 9.36M | Sep 29, 2024 |
| Novo Holdings A/S | 4.29% | 1,850,000 | 7.25M | Sep 29, 2024 |
| Blackrock Inc. | 3.52% | 1,520,261 | 5.96M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| JP Morgan Small Cap Growth Fund | 2.39% | 1,031,546 | 4.04M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 1.47% | 633,844 | 2.48M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.05% | 451,759 | 1.77M | Oct 30, 2024 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 0.57% | 244,900 | 960.01K | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 0.54% | 232,962 | 913.21K | Sep 29, 2024 |
| Franklin Strategic Series-Franklin Small Cap Growth Fund | 0.52% | 224,100 | 878.47K | Jul 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 11, 2024 | 0 |
| COHEN FREDERICK E. M.D. PH.D. | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 11, 2024 | 0 |
| GILEAD SCIENCES INC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 11, 2024 | 4,126,120 |
| JONES RYAN ALEXANDER | Chief Financial Officer | Conversion of Exercise of derivative security | May 27, 2024 | 43,950 |
| NORTHPOND VENTURES III GP, L.L.C. | Former | Purchase | Feb 11, 2024 | 0 |
| SEIDENBERG BETH C | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 11, 2024 | 0 |